Metal Drugs and the Anticancer Immune Response

Area of Science:

• Oncology
• Immunology
• Pharmacology

Background:

• The immune system's surveillance prevents cancer, but tumors evade detection.
• Clinically apparent tumors indicate successful immune evasion by malignant cells.

Purpose of the Study:

• To review the interaction between metal drugs and anticancer immune responses.
• To explore the potential of metal drugs in reversing immune evasion and enhancing immunotherapy.

Main Methods:

• Literature review of existing studies on metal drugs and cancer immunity.
• Analysis of the impact of metal drugs on immune surveillance and evasion mechanisms.

Main Results:

• Metal drugs, beyond cytotoxicity, significantly influence the cancer-immune interface.
• Metal compounds can reverse immune evasion, potentially inducing long-lasting anticancer immune responses.
• These effects involve altered cancer cell visibility, immune cell modulation, and tumor microenvironment changes.

Conclusions:

• Metal drugs hold promise for combination therapies with immunotherapy.
• Further research and multidisciplinary approaches are needed to develop novel anticancer metal compounds targeting immune responses.